TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $29,632,000 | -45.8% | 393,782 | -80.6% | 0.01% | -33.3% |
| Q1 2022 | $54,641,000 | -43.0% | 2,035,049 | +1.3% | 0.02% | -38.2% |
| Q4 2021 | $95,838,000 | +15.2% | 2,009,191 | +60.4% | 0.03% | +3.0% |
| Q3 2021 | $83,222,000 | -25.8% | 1,252,773 | -12.9% | 0.03% | -26.7% |
| Q2 2021 | $112,224,000 | +12.4% | 1,438,406 | +36.2% | 0.04% | +2.3% |
| Q1 2021 | $99,876,000 | -13.3% | 1,055,886 | +11.7% | 0.04% | -18.5% |
| Q4 2020 | $115,198,000 | +22.2% | 945,411 | -12.4% | 0.05% | +5.9% |
| Q3 2020 | $94,270,000 | +27.7% | 1,079,096 | -5.6% | 0.05% | +18.6% |
| Q2 2020 | $73,805,000 | +172.9% | 1,142,671 | +88.7% | 0.04% | +126.3% |
| Q1 2020 | $27,044,000 | -21.0% | 605,558 | +10.2% | 0.02% | 0.0% |
| Q4 2019 | $34,238,000 | +103.0% | 549,657 | +22.5% | 0.02% | +72.7% |
| Q3 2019 | $16,868,000 | +3.8% | 448,628 | +12.3% | 0.01% | +10.0% |
| Q2 2019 | $16,257,000 | – | 399,436 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |